Flovent, a popular corticosteroid inhaler used to treat asthma, is no longer available. The global manufacturer, Glaxo Smith Kline (GSK), announced in May that the medications — Flovent HFA ...

People using the popular corticosteroid inhalers Flovent HFA or Flovent Diskus to treat their asthma will need to switch to a new product in 2024. Flovent manufacturer GlaxoSmithKline announced in ...

When a person’s asthma is severe or isn’t managed well by typical protocols, they may be a good candidate for pulmonary ...

GP and respiratory expert Dr Andrew Whittamore outlines the key updates in new joint NICE/BTS/SIGN asthma guidelines and ...

Singulair, a popular asthma medication, could be linked to severe side effects, including suicide, a study from the FDA found ...

Massachusetts families are still struggling to find alternatives almost a year after GlaxoSmithKline canceled a widely ...

The advice said switching to dry powder inhalers will have a beneficial effect on climate change, however stressed that asthma sufferers should choose or stick with the treatment that worked best for ...

Inhalers and nebulizers play a key role in delivering medication to the lungs, making it easier for people with breathing ...

A new injection, benralizumab, outperforms traditional steroids in treating asthma and COPD attacks, reducing treatment ...

A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers ... or prevention of asthma symptoms ...

open image in gallery A senior woman uses her inhaler. New research has found that one in six US adults are stopped from taking their asthma medication as it has been prescribed due to its cost ...